Skip to main content
The United States Army

Stand-To: Procedure prior to first light to enhance unit security, a daily compendium of news, information, and context for Army leaders.

subscribe today

STAND-TO! Edition: Thursday, October 11 2012

Today's Focus:

Breast Cancer Awareness Month

Senior Leaders are Saying

During National Breast Cancer Awareness Month, we honor those we have lost, lend our strength to those who carry on the fight, and pledge to educate ourselves and our loved ones about this tragic disease.

- President Barack Obama

View the complete: Presidential Proclamation -- National Breast Cancer Awareness Month, 2012

What They're Saying

On the research front, the Army has always emphasized prevention of diseases for force health protection and readiness and in that context, the Army has been directly or indirectly involved in the research and development of more vaccines than any other organization in the world -- over 30 presently licensed vaccines.

- Dr. Edmund C. Tramont, a retired Army doctor who helped develop vaccines to protect troops from meningitis, AIDS, hepatitis, diarrhea, and many other infectious diseases, will be presented the Outstanding Civilian Service Award by the Chief of Staff of the Army Gen. Raymond D. Odierno, during a Twilight Tattoo, today, at Joint Base Myer-Henderson Hall, Va.

Army to honor doctor for fighting deadly viruses

Related site: Ready and Resilient

A Culture of Engagement


150 Years: The Battle of Gettysburg: The American Civil War


Sept 15- Oct 15: National Hispanic Heritage Month

Energy Awareness Month

National Depression Awareness Month- Army Behavioral Health

National Domestic Violence Awareness Month

National Disability Employment Awareness Month

Oct. 22- 24: Association of the Unites States Army Annual Meeting and Exposition (AUSA), Washington D.C.

Today's Focus

Breast Cancer Awareness Month

What is it?

Breast cancer is the most commonly diagnosed non-skin cancer in women. This year, approximately 226,870 women in the U.S. will receive a diagnosis of invasive breast cancer and 63,300 women will be diagnosed with in situ (in one location) breast cancer. In addition, about 2,190 men will be diagnosed with breast cancer this year. Breast cancer is the second leading cause of cancer deaths in women in the United States. It is anticipated that approximately 39,510 women and 410 men in the U.S. will die from breast cancer this year.

What has the Army done?

The United States Army Medical Research and Materiel Command (MRMC) is the executor of DOD's Breast Cancer Research Program (BCRP). Their continued efforts have resulted in more than $2.6 billion in congressional appropriations through fiscal year 2011. The BCRP vision is adapted yearly to ensure that the program remains responsive to what is currently happening in the research community.

In 1992, the Army began its own breast cancer research program in conjunction with acquiring mammography equipment. That year, a highly visible lobbying campaign by grassroots advocacy organizations, primarily the National Breast Cancer Coalition, increased awareness among policymakers of the need to expand funding for breast cancer research. In response, the Congress allocated specific funds for breast cancer research and the Congressionally Directed Medical Research Programs were formed to execute peer reviewed funding in breast cancer. From 1992 to 2011, over $2.6 billion dollars have been included in appropriations. During the past 20 years, BCRP has funded over 6,100 research awards and brought forward new diagnostics, therapeutic drugs, mammography registries for surveillance, improved website information, advances in identification of genetic bio-markers, and therapeutic development using nanotechnology.

What continued efforts does the Army have planned for the future?

As requested by Congress, the Army's Medical Research and Materiel Command will continue to fund innovative research in breast cancer and partner with Tri-Services and the Veterans Administration to bring research advances forward for evidence based prevention, diagnosis, and treatment of breast cancer.

Why is it important to the Army?

Early detection of breast cancer can provide early treatment for the service member and beneficiaries. For those diagnosed with localized (stage 1) breast cancer there is over a 98% probability they will survive five or more years. Lowering the risk of death from breast cancer contributes to the Army's overall readiness and well being of those who serve.


Army Breast Cancer Research Program

American Cancer Society

National Cancer Institute

External Links Disclaimer - The appearance of hyperlinks to external sites does not constitute endorsement by the Department of the U.S. Army of the linked web site or the information, products or services contained therein. For other than authorized activities such as military exchanges and Morale, Welfare and Recreation sites, the Department of the U.S. Army does not exercise any editorial control over the information you may find at these locations. Such links are provided consistent with the stated purpose of this DoD web site.